CX 2023: Consensus update marks 45 years of looking forward

New data and global discussion will be the hallmarks of the upcoming Charing Cross (CX) International Symposium, which this year celebrates its 45th anniversary. The 2023 programme offers a consensus update on key topics in the vascular and endovascular space—from revascularisation strategies for patients with chronic limb-threatening ischaemia (CLTI), to treatment options for superficial venous disease. The symposium will bring together world-leading experts and feature three days of in-person education in London, UK, as well as virtual and on-demand viewing options that will be beamed across the globe.

Running from 25th–27th April, the programme will aim to reach consensus on pressing issues in multiple vascular domains, including peripheral arterial, aortic, venous, vascular access, acute stroke, vascular trauma and—for the first time—the wide field of renal interventions.

CX welcomes new co-chairs

This year, CX welcomes three new co-chairs from across the globe to the leadership team. Dittmar Böckler, medical director of the Clinic for Vascular and Endovascular Surgery at University Hospital Heidelberg (Heidelberg, Germany), Andrew Holden, director of Interventional Radiology at Auckland City Hospital (Auckland, New Zealand) and Erin Murphy, director of the Venous and Lymphatic Institute at Sanger Heart and Vascular, Atrium Health (Charlotte, USA) will work alongside CX chair and anchor Roger Greenhalgh (Imperial College London, London, UK) to deliver the CX programme.

Podium First highlight: BASIL-2

The key highlight of this year’s programme is the BASIL-2 (Bypass versus angioplasty in severe ischaemia of the leg-2) Podium First presentation, which will be published simultaneously in The Lancet. Chief investigator Andrew Bradbury (University of Birmingham, Birmingham, UK) and other members of the trial group will deliver the findings, after which attendees in London and remote participants will have the opportunity to pose questions. A roundtable discussion is planned to include invited commentary from Eleni Whatley (US Food and Drug Administration [FDA], Silver Spring, USA) and UK Secretary of State for Health Steve Barclay (London, UK).

New data

Alongside BASIL-2, there are 12 other Podium First presentations on this year’s CX programme. In the Peripheral Arterial session, stay tuned for new data from the BEST-CLI (Best endovascular versus best surgical therapy for patients with critical limb ischaemia) trial, with Matthew Menard (Brigham and Women’s Hospital, Boston, USA) due to give a clinical trial update and Alik Farber (Boston Medical Center, Boston, USA) an insight into the quality of life data from the study.

The Aortic programme will feature five Podium First presentations, including

CX will run 25th to 27th April one by Kevin Mani (Uppsala University, Uppsala, Sweden) on statin treatment, and the Vascular Access Masterclass will see Holden, CX co-chair and executive board member, present a three-year data subanalysis from the IN.PACT AV Access study.

Innovation

The CX Innovation Showcase returns for 2023, bringing to the fore an array of cutting-edge technologies and techniques. The CX audience can expect to see presentations on topics ranging from the power of intelligent mapping for complex endovascular aneurysm repair (EVAR), to wearable devices for non-invasive, remote monitoring and classification of access patency and flow characteristics in haemodialysis patients. The session will close with the annual Dragon’s Den-style competition and announcement of the winner of this year’s £1,000 CX Innovation prize.

Hands-on learning

A series of workshops will provide CX attendees with the opportunity to test and improve their practical skills at hands- on stations showcasing techniques and technologies across all three days of the meeting.

In a dedicated Workshop Wing, attendees will be able visit the Vascular Access Workshop on Tuesday 25th April, the Aortic Workshop on Wednesday 26th April and the Venous and Hurting Leg Workshop on Thursday 27th April.

Global reach

This year’s in-person symposium will be held in the Hilton London Metropole, however there will also be a broadcastquality livestream available to enable participants who cannot be in London to join the global vascular conversation. The CX International Symposium has a global audience and every year sees participation from around the world. There will be a dedicated CX Meets Latin America session at this year’s meeting, with presenters from Brazil and Argentina sharing their research with the global CX audience.

For more information and to register for CX 2023, visit www.cxsymposium.com. Join the global vascular discussion.